Cerebrospinal-fluid vasopressin in neurological and psychiatric-disorders

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

Schumacher, G. A., Beebe, G., Kibler, R. F., Kurland, L. T., Kurtzke, J. F., McDowell, F., Nagler, B., Sibley, W. A., Tourtellotte, W. W., & Willmon, T. L. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb20235.x · Cited by 1,438 · see citing works

Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat

Buijs, R. M., Swaab, D. F., Dogterom, J., & van Leeuwen, F. W. (1978) · Cell and Tissue Research · doi:10.1007/bf00224932 · Cited by 1,029 · see citing works

The Bech‐Rafaelsen Mania Scale and the Hamilton Depression Scale

Bech, P., Bolwig, T. G., Kramp, P., & Rafaelsen, O. J. (1979) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1979.tb04484.x · Cited by 405 · see citing works

The influence of the posterior and inter-mediate lobe of the pituitary and pituitary peptides on the maintenance of a conditioned avoidance response in rats

Wled, D. D. (1965) · International Journal of Neuropharmacology · doi:10.1016/0028-3908(65)90005-5 · Cited by 377 · see citing works

COMPARISON OF WEIGHT REDUCTION WITH METOPROLOL IN TREATMENT OF HYPERTENSION IN YOUNG OVERWEIGHT PATIENTS

MacMahon, S. W., Bernstein, L., Macdonald, G., Andrews, G., & Blacket, R. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92310-4 · Cited by 365 · see citing works

Effects of Vasopressin on Human Memory Functions

Weingartner, H., Gold, P. W., Ballenger, J. C., Smallberg, S. A., Summers, R. L., Rubinow, D. R., Post, R. M., & Goodwin, F. K. (1981) · Science · doi:10.1126/science.7455701 · Cited by 315 · see citing works

INFLUENCE OF VASOPRESSIN ON LEARNING AND MEMORY

Legros, J.-J., Gilot, P., Seron, X., Claessens, J., Adam, A. A., Moeglen, J. M., Audibert, A., & Berchier, P. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90386-0 · Cited by 220 · see citing works

Regulation of brain water permeability by centrally-released vasopressin

Raichle, M. E., & Grubb, R. L. (1978) · Brain Research · doi:10.1016/0006-8993(78)90766-7 · Cited by 212 · see citing works

The use of rating scales exemplified by a comparison of the Hamilton and the Bech‐Rafaelsen Melancholia Scale

Bech, P., & Rafaelsen, O. J. (1980) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1980.tb07683.x · Cited by 171 · see citing works

Vasopressin and Memory Consolidation

de Wied, D., Greidanus, T. B. V. W., Bohus, B., Urban, I. J. A., & Gispen, W. H. (1976) · Progress in brain research · doi:10.1016/s0079-6123(08)60990-5 · Cited by 166 · see citing works

VASOPRESSIN IN AFFECTIVE ILLNESS

Gold, P., Goodwin, F., & Reus, V. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92467-4 · Cited by 152 · see citing works

IMMUNOGLOBULIN STANDARDS

Soothill, J. F., Humphrey, J., & Batty, I. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92401-0 · Cited by 152 · see citing works

Investigation of Cerebrospinal Fluid Neuropeptides in Idiopathic Senile Dementia

Oram, J. J., Edwardson, J. A., & Millard, P. H. (2009) · Gerontology · doi:10.1159/000212476 · Cited by 105 · see citing works

Brain Water Accumulation after the Central Administration of Vasopressin

D�czi, T., Szerdahelyi, P., Gulya, K., & Kiss, J. (1982) · Neurosurgery · doi:10.1227/00006123-198209000-00011 · Cited by 98 · see citing works

Vasopressin in Human Cerebrospinal Fluid*

JESKINS, J. S., Mather, H. M., & Ang, V. T. Y. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-2-364 · Cited by 96 · see citing works

The resistance to cerebrospinal fluid absorption in humans

Børgesen, S. E., Gjerris, F., & Sørensen, S. J. (1978) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1978.tb04500.x · Cited by 96 · see citing works

The hypothalamo-choroidal tract

Brownfield, M. S., & Kozlowski, G. P. (1977) · Cell and Tissue Research · doi:10.1007/bf00232829 · Cited by 88 · see citing works

Vasopressin in plasma and CSF of patients with subarachnoid haemorrhage.

Mather, H. M., Ang, V. T. Y., & Jenkins, J. S. (1981) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.44.3.216 · Cited by 88 · see citing works

Blood–cerebrospinal fluid barrier to arginine-vasopressin, desmopressin and desglycinamide arginine-vasopressin in the dog

Ang, V. T. Y., & Jenkins, J. S. (1982) · Journal of Endocrinology · doi:10.1677/joe.0.0930319 · Cited by 85 · see citing works

ARGININE VASOPRESSIN AND CHOLINE ACETYLTRANSFERASE IN BRAINS OF PATIENTS WITH ALZHEIMER TYPE SENILE DEMENTIA

Rossor, M. N., Iversen, L. L., Mountjoy, C. Q., Roth, M., Hawthorn, J., Ang, V., & Jenkins, J. S. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92428-9 · Cited by 80 · see citing works

Localization of vasopressin in the rat brain

Hawthorn, J., Ang, V. T. Y., & Jenkins, J. S. (1980) · Brain Research · doi:10.1016/0006-8993(80)90435-7 · Cited by 76 · see citing works

Vasopressin treatment of cognitive dysfunction un progressive dementia

Weingartner, H., Kaye, W. H., Gold, P. W., Smallberg, S. A., Peterson, R., Gillin, J. C., & Ebert, M. H. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90531-2 · Cited by 69 · see citing works

Extrahypothalamic vasopressin in human brain

Rossor, M. N., Iversen, L. L., Hawthorn, J., Ang, V. T. Y., & Jenkins, J. S. (1981) · Brain Research · doi:10.1016/0006-8993(81)91199-9 · Cited by 66 · see citing works

Cerebrospinal fluid arginine vasopressin in degenerative disorders and other neurological diseases.

Sundquist, J., Forsling, M. L., Olsson, J. E., & Åkerlund, M. (1983) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.46.1.14 · Cited by 56 · see citing works

Cerebrospinal Fluid Vasopressin and Vasotocin in Health and Disease

Luerssen, T. G., & Robertson, G. L. (1980) · Springer eBooks · doi:10.1007/978-1-4684-1039-6_43 · Cited by 55 · see citing works

Cerebrospinal fluid vasopressin and increased intracranial pressure

Sørensen, P. S., Gjerris, F., & HAMMER, M. (1984) · Annals of Neurology · doi:10.1002/ana.410150506 · Cited by 52 · see citing works

CSF and plasma vasopressin concentrations in dementia.

Sørensen, P. S., HAMMER, M., Vorstrup, S., & Gjerris, F. (1983) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.46.10.911 · Cited by 52 · see citing works

Relationship between plasma osmolality and plasma vasopressin in human subjects.

Hammer, M., Ladefoged, J., & Olgaard, K. (1980) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1980.238.4.e313 · Cited by 52 · see citing works

Lysine vasopressin in Alzheimer disease

Durso, R., Fedio, P., Brouwers, P. Y., Cox, C., Martin, A. J., Ruggieri, S. A., Tamminga, C. A., & Chase, T. N. (1982) · Neurology · doi:10.1212/wnl.32.6.674 · Cited by 41 · see citing works

Radioimmunoassay of 8-arginine-vasopressin (antidiuretic hormone) in human plasma

HAMMER, M. (1978) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365517809104877 · Cited by 40 · see citing works

Effect of vasopressin on intracranial pressure of rabbit.

Noto, T., Nakajima, T., Saji, Y., & Nagawa, Y. (1978) · Endocrinologia Japonica · doi:10.1507/endocrj1954.25.591 · Cited by 39 · see citing works

DESMOPRESSIN AND DESGLYCINAMIDE VASOPRESSIN IN POST-TRAUMATIC AMNESIA

Jenkins, J. S., Mather, H. M., Coughlan, A., & Jenkins, D. G. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90137-9 · Cited by 39 · see citing works

Impermeability of the blood‐cerebrospinal fluid barrier to 1‐deamino‐8‐D‐arginine‐vasopressin (DDAVP) in patients with acquired, communicating hydrocephalus

Sørensen, P. S., Vilhardt, H., Gjerris, F., & Warberg, J. (1984) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1984.tb01209.x · Cited by 38 · see citing works

Vasopressin in the cerebrospinal fluid of patients with normal pressure hydrocephalus and benign intracranial hypertension

HAMMER, M., Sørensen, P. S., Gjerris, F., & Larsen, K. (1982) · European Journal of Endocrinology · doi:10.1530/acta.0.1000211 · Cited by 35 · see citing works

Cerebrospinal fluid vasopressin in benign intracranial hypertension

Sørensen, P. S., HAMMER, M., & Gjerris, F. (1982) · Neurology · doi:10.1212/wnl.32.11.1255 · Cited by 34 · see citing works

CSF vasopressin and cyclic nucleotide concentrations in senile dementia

Tsuji, M. (1981) · Psychoneuroendocrinology · doi:10.1016/0306-4530(81)90009-3 · Cited by 31 · see citing works

Cerebrospinal fluid concentration of arginine vasopressin in children with bacterial meningitis

Garcia, H., Kaplan, S. L., & Feigin, R. D. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80537-9 · Cited by 31 · see citing works

Immunohistochemical Localization of Hypothalamic Peptide Hormones in Neural Target Areas1

Weindl, A., & Sofroniew, M. V. (2015) · KARGER eBooks · doi:10.1159/000385201 · Cited by 28 · see citing works

Arginine vasopressin levels in cerebrospinal fluid in neurological disease

Reid, A. C., & Morton, J. J. (1982) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(82)90190-3 · Cited by 23 · see citing works

Vasopressin function in depression and mania [proceedings].

Pw, G., Fk, G., Post, R. M., & Robertson, G. L. (1981) · PubMed · Cited by 22 · see citing works

Vasopressin and Physostigmine in the Treatment of Amnesia

Franceschi, M., Tancredi, O., Savio, G., & Smirne, S. (2008) · European Neurology · doi:10.1159/000115511 · Cited by 18 · see citing works

HYPOTHALAMUS AND DEMENTIA

Mann, D. M. A., Yates, P. O., Bansal, D. V., & Marshall, D. J. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91721-9 · Cited by 17 · see citing works

Vasopressin release during electroconvulsive therapy

Sørensen, P. S., Hammer, M., & Bolwig, T. G. (1982) · Psychoneuroendocrinology · doi:10.1016/0306-4530(82)90034-8 · Cited by 14 · see citing works

A placebo‐controlled trial shows no effect of vasopressin on recovery from closed head injury

Reichert, W. H., & Blass, J. P. (1982) · Annals of Neurology · doi:10.1002/ana.410120412 · Cited by 13 · see citing works

A VASOPRESSIN HYPOTHESIS OF AFFECTIVE ILLNESS: PRELIMINARY FINDINGS

Gold, P. W., Ballenger, J. C., Zis, A. P., Robertson, G. L., Post, R. M., & Goodwin, F. K. (1979) · Elsevier eBooks · doi:10.1016/b978-1-4832-8363-0.50360-8 · Cited by 7 · see citing works

The levels of vasopressin in cerebrospinal fluid of patients with alcoholism.

Noto, T., Kato, N., Inoue, K., KITABAYASHI, M., & Nakajima, T. (1982) · Endocrinologia Japonica · doi:10.1507/endocrj1954.29.121 · Cited by 7 · see citing works

Cerebrospinal Fluid Vasopressin Levels

Coccaro, E. F., Kavoussi, R. J., Hauger, R. L., Cooper, T. B., & Ferris, C. F. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.8.708 · Cited by 392 · see citing works

Localization of high-affinity binding sites for oxytocin and vasopressin in the human brain. An autoradiographic study

Loup, F., Tribollet, E., Dubois-Dauphin, M., & Dreifuss, J. J. (1991) · Brain Research · doi:10.1016/0006-8993(91)90345-v · Cited by 378 · see citing works

Plasma Levels of Arginine Vasopressin Elevated in Patients with Major Depression

van Londen, L. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00054-7 · Cited by 306 · see citing works

Mechanisms of Altered Water Metabolism in Psychotic Patients with Polydipsia and Hyponatremia

Goldman, M. B., Luchins, D. J., & Robertson, G. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802183180702 · Cited by 295 · see citing works

Bumetanide Inhibition of the Blood-Brain Barrier Na-K-Cl Cotransporter Reduces Edema Formation in the Rat Middle Cerebral Artery Occlusion Model of Stroke

O’Donnell, M. E., Tran, L., Lam, T. I., Liu, X. B., & Anderson, S. E. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000130867.32663.90 · Cited by 250 · see citing works

Elevated Cerebrospinal Fluid Levels of Oxytocin in Obsessive-compulsive Disorder: Comparison With Tourette's Syndrome and Healthy Controls

Leckman, J. F. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950100030003 · Cited by 209 · see citing works

Abnormalities in the Regulation of Vasopressin and Corticotropin Releasing Factor Secretion in Obsessive-Compulsive Disorder

Altemus, M. M. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820010009002 · Cited by 186 · see citing works

Oxytocin and vasopressin effects on the neural response to social cooperation are modulated by sex in humans

Feng, C., Hackett, P. D., DeMarco, A. C., Chen, X., Stair, S., Haroon, E., Ditzen, B., Pagnoni, G., & Rilling, J. K. (2015) · Brain Imaging and Behavior · doi:10.1007/s11682-014-9333-9 · Cited by 157 · see citing works

Innovative Approaches for the Treatment of Depression: Targeting the HPA Axis

THOMSON, F. J., & Craighead, M. W. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9518-3 · Cited by 155 · see citing works

Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis

Rutigliano, G., Rocchetti, M., Paloyelis, Y., Gilleen, J., Sardella, A., Cappucciati, M., Palombini, E., Dell’Osso, L., Caverzasi, E., Politi, P., et al. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.04.117 · Cited by 149 · see citing works

The Central Vasopressinergic System: Examining the Opportunities for Psychiatric Drug Development

Ring, R. H. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382241 · Cited by 141 · see citing works

Cerebral microvascular endothelial cell Na/H exchange: evidence for the presence of NHE1 and NHE2 isoforms and regulation by arginine vasopressin

Lam, T. I., Wise, P. M., & O’Donnell, M. E. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00093.2009 · Cited by 77 · see citing works

Vasopressin Amplifies the Production of Proinflammatory Mediators in Traumatic Brain Injury

Szmydynger‐Chodobska, J., Fox, L. M., Lynch, K. M., Zink, B. J., & Chodobski, A. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1331 · Cited by 75 · see citing works

Blood–Brain Barrier Na Transporters in Ischemic Stroke

O’Donnell, M. E. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.06.011 · Cited by 73 · see citing works

Arginine vasopressin stimulation of cerebral microvascular endothelial cell Na-K-Cl cotransporter activity is V1 receptor and [Ca] dependent

O’Donnell, M. E., Duong, V., Suvatne, J., Foroutan, S., & Johnson, D. M. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00001.2005 · Cited by 73 · see citing works

Bumetanide Reduces Cerebral Edema Formation in Rats With Diabetic Ketoacidosis

Lam, T. I., Anderson, S. E., Glaser, N. S., & O’Donnell, M. E. (2005) · Diabetes · doi:10.2337/diabetes.54.2.510 · Cited by 71 · see citing works

Attenuated Development of Ischemic Brain Edema in Vasopressin-Deficient Rats

Dickinson, L. D., & Betz, A. L. (1992) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1992.93 · Cited by 70 · see citing works

Cerebrospinal Fluid Vasopressin—Changes in Depression

Gjerris, A., Vendsborg, P. B., HAMMER, M., Christensen, N. J., & Rafaelsen, O. J. (1985) · The British Journal of Psychiatry · doi:10.1192/bjp.147.6.696 · Cited by 69 · see citing works

Selective vasopressin-1a receptor antagonist prevents brain edema, reduces astrocytic cell swelling and GFAP, V1aR and AQP4 expression after focal traumatic brain injury

Marmarou, C. R., Liang, X., Abidi, N. H., Parveen, S., Taya, K., Henderson, S. C., Young, H. F., Filippidis, A., & Baumgarten, C. M. (2014) · Brain Research · doi:10.1016/j.brainres.2014.06.005 · Cited by 64 · see citing works

No vasopressin cell loss in the human hypothalamus in aging and Alzheimer's disease

Woude, P. F. V. D., Goudsmit, E., Wierda, M., Purba, J. S., Hofman, M. A., Bogte, H., & Swaab, D. F. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)80003-a · Cited by 63 · see citing works

Effects of estradiol on ischemic factor-induced astrocyte swelling and AQP4 protein abundance

Rutkowsky, J. M., Wallace, B. K., Wise, P. M., & O’Donnell, M. E. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00399.2010 · Cited by 60 · see citing works

CSF oxytocin and vasopressin levels after recovery from bulimia nervosa and anorexia nervosa, bulimic subtype

Frank, G., Kaye, W. H., Altemus, M. M., & Greeno, C. G. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00243-2 · Cited by 60 · see citing works

Increased Expression of Vasopressin V 1a Receptors after Traumatic Brain Injury

Szmydynger‐Chodobska, J., Chung, I., Koźniewska, E., Tran, B. G., Harrington, F. J., Duncan, J. A., & Chodobski, A. (2004) · Journal of Neurotrauma · doi:10.1089/0897715041651033 · Cited by 59 · see citing works

Vasopressin in Alzheimer's disease: A study of postmortem brain concentrations

Mazurek, M. F., Bed, M. F., Bird, E. D., & Martin, J. B. (1986) · Annals of Neurology · doi:10.1002/ana.410200603 · Cited by 59 · see citing works

Mitochondria, Oxytocin, and Vasopressin: Unfolding the Inflammatory Protein Response

Bordt, E. A., Smith, C. J., Demarest, T. G., Bilbo, S. D., & Kingsbury, M. A. (2019) · Neurotoxicity Research · doi:10.1007/s12640-018-9962-7 · Cited by 58 · see citing works

Hypoxia effects on cell volume and ion uptake of cerebral microvascular endothelial cells

Brillault, J., Lam, T. I., Rutkowsky, J. M., Foroutan, S., & O’Donnell, M. E. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00148.2007 · Cited by 58 · see citing works

Evaluation of the Secretory Pattern of Plasma Arginine Vasopressin in Stroke Patients

BARRECA, T., Gandolfo, C., Corsini, G. P., Sette, M. D., Cataldi, A., Rolandi, E., & FRANCESCHINI, R. (2001) · Cerebrovascular Diseases · doi:10.1159/000047622 · Cited by 58 · see citing works

Neuropeptides involved in the pathophysiology of schizophrenia and major depression

de Wied, D., & Sigling, H. O. (2002) · Neurotoxicity Research · doi:10.1080/10298420290031432 · Cited by 52 · see citing works

Evaluation of delayed treatment of focal cerebral ischemia with three selective kappa-opioid agonists in cats.

Baskin, D. S., Widmayer, M. A., Browning, J. L., Heizer, M. L., & Schmidt, W. K. (1994) · Stroke · doi:10.1161/01.str.25.10.2047 · Cited by 52 · see citing works

Structural studies of the hypothalamus and its nuclei in mood disorders

Schindler, S., Geyer, S., Strauß, M., Anwander, A., Hegerl, U., Turner, R., & Schönknecht, P. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.06.005 · Cited by 49 · see citing works

The cerebello-hypothalamic–pituitary–adrenal axis dysregulation hypothesis in depressive disorder

Schutter, D. J. L. G. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.08.027 · Cited by 47 · see citing works

Neuronal hypertrophy in the human supraoptic and paraventricular nucleus in aging and Alzheimer's disease

Vogels, O. J. M., Broere, C. A. J., & Nieuwenhuys, R. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90538-k · Cited by 45 · see citing works

Endocrine Studies in Patients With Pseudotumor Cerebri

Sørensen, P. S. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520090038013 · Cited by 44 · see citing works

Treatment of Brain Edema with a Nonpeptide Arginine Vasopressin V1 Receptor Antagonist OPC-21268 in Rats

Bemana, I., & Nagao, S. (1999) · Neurosurgery · doi:10.1097/00006123-199901000-00091 · Cited by 43 · see citing works

Chapter 16 The human hypothalamo-neurohypophyseal system in relation to development, aging and Alzheimer's disease

Goudsmit, E., Neijmeijer-Leloux, A., & Swaab, D. F. (1992) · Progress in brain research · doi:10.1016/s0079-6123(08)64575-6 · Cited by 41 · see citing works

Studies of vasopressin in the human cerebrospinal fluid

Sørensen, P. S. (1986) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1986.tb04633.x · Cited by 41 · see citing works

Neuropeptide and Sigma Receptors as Novel Therapeutic Targets for the Pharmacotherapy of Depression

Paschos, K. A., Veletza, S. V., & Chatzaki, Ε. (2009) · CNS Drugs · doi:10.2165/11310830-000000000-00000 · Cited by 36 · see citing works

Plasma arginine-vasopressin following experimental stroke: effect of osmotherapy

Chang, Y., Chen, T., Chen, C., Crain, B. J., Toung, T. J. K., & Bhardwaj, A. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00763.2005 · Cited by 35 · see citing works

Plasma and cerebrospinal fluid arginine vasopressin in patients with and without fever.

Sharples, P. M., Seckl, J. R., Human, D., Lightman, S. L., & Dunger, D. B. (1992) · Archives of Disease in Childhood · doi:10.1136/adc.67.8.998 · Cited by 34 · see citing works

Involvement of Neuropeptide Systems in Schizophrenia: Human Studies

Cáceda, R., Kinkead, B. L., & Nemeroff, C. B. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78011-4 · Cited by 33 · see citing works

Microelectrode Biosensors for in vivo Analysis of Brain Interstitial Fluid

Chatard, C., Meiller, A., & Marinesco, S. (2018) · Electroanalysis · doi:10.1002/elan.201700836 · Cited by 32 · see citing works

Endocrine abnormalities and outcome of ischaemic stroke

FRANCESCHINI, R., Tenconi, G. L., Zoppoli, F., & BARRECA, T. (2001) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(01)00086-5 · Cited by 32 · see citing works

Multiple Sites of Vasopressin Synthesis in the Injured Brain

Szmydynger‐Chodobska, J., Zink, B. J., & Chodobski, A. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.188 · Cited by 30 · see citing works

Vasopressin Gene Expression in Rat Choroid Plexus

Chodobski, A., Wojcik, B. E., Loh, Y. P., Dodd, K. A., Szmydynger‐Chodobska, J., Johanson, C. E., Demers, D. M., Chun, Z. G., & Limthong, N. P. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_6 · Cited by 29 · see citing works

Hormonal Aspects of Fluid and Sodium Balance in the Elderly

Miller, M. (1995) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30040-9 · Cited by 29 · see citing works

Neuropeptide modulation of central vestibular circuits.

Balaban, C. D., Starcevic, V. P., & Severs, W. B. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00023-7 · Cited by 29 · see citing works

Chapter 8 Neuropeptides and dementia

Rossor, M. N., Emson, P. C., Dawbarn, D., Mountjoy, C. Q., & Roth, M. (1986) · Progress in brain research · doi:10.1016/s0079-6123(08)64603-8 · Cited by 29 · see citing works

Arginine Vasopressin V 1a Receptor-Deficient Mice Have Reduced Brain Edema and Secondary Brain Damage following Traumatic Brain Injury

Rauen, K., Trabold, R., Brem, C., Terpolilli, N. A., & Plesnila, N. (2013) · Journal of Neurotrauma · doi:10.1089/neu.2012.2807 · Cited by 28 · see citing works

The Role of the Blood-Brain Barrier Na-K-2Cl Cotransporter in Stroke

O’Donnell, M. E., Lam, T. I., Tran, L., & Anderson, S. E. (2006) · Springer eBooks · doi:10.1007/0-387-23752-6_6 · Cited by 27 · see citing works

Stimulation of the pituitary-adrenal axis with a low dose [Arg8]-vasopressin in depressed patients and healthy subjects

Wied, C. C. G., Westenberg, H. G. M., Koppeschaar, H. P. F., Thijssen, J. H. H., & van Ree, J. M. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90003-q · Cited by 27 · see citing works

Arginine Vasopressin Receptor Antagonists for Treatment of Vasogenic Brain Edema: An Experimental Study

Kagawa, M., Nagao, S., & Bemana, I. (1996) · Journal of Neurotrauma · doi:10.1089/neu.1996.13.273 · Cited by 27 · see citing works

Fear and power-dominance motivation: proposed contributions of peptide hormones present in cerebrospinal fluid and plasma

Sewards, T. V., & Sewards, M. A. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00034-4 · Cited by 26 · see citing works

AVP- and OT-neurophysins response to apomorphine and clonidine in major depression

Scantamburlo, G., Hansenne, M., Fuchs, S., Pitchot, W., Pinto, E., Reggers, J., Ansseau, M., & Legros, J. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.04.015 · Cited by 26 · see citing works

Neuropeptides and Alzheimer's disease

Gottfries, C., Frederiksen, S. O., & Heilig, M. (1995) · European Neuropsychopharmacology · doi:10.1016/0924-977x(95)80009-q · Cited by 26 · see citing works

Cerebrospinal fluid neurohypophysial peptides in benign intracranial hypertension.

Seckl, J. R., & Lightman, S. L. (1988) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.12.1538 · Cited by 24 · see citing works

Neurohypophysial Peptides in Cerebrospinal Fluid: An Update

Robinson, I. C. A. F., & Coombes, J. E. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb55553.x · Cited by 24 · see citing works

Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: A randomized, double-blind, placebo-controlled, clinical trial

Hosseini, S. M. R., Farokhnia, M., Rezaei, F., Gougol, A., Yekehtaz, H., Iranpour, N., Salehi, B., Tabrizi, M. H., Tajdini, M., Ghaleiha, A., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.02.001 · Cited by 23 · see citing works

Baseline studies on transmitter substances in cerebrospinal fluid in depression

Gjerris, A. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb10571.x · Cited by 22 · see citing works

Arginine vasopressin release inhibitor RU51599 attenuates brian oedema following transient forebrain ischaemia in rats

Ikeda, Y., Toda, S., Kawamoto, T., & Teramoto, A. (1997) · Acta Neurochirurgica · doi:10.1007/bf01410978 · Cited by 22 · see citing works

Alterations in Neuropeptides in Aging and Disease

Leake, A., & Ferrier, I. N. (1993) · Drugs & Aging · doi:10.2165/00002512-199303050-00003 · Cited by 21 · see citing works

An evaluation of human neurophysin production in Alzheimer's disease: Preliminary observations

North, W. G., Harbaugh, R. E., & Reeder, T. M. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90038-y · Cited by 20 · see citing works

Cerebrospinal Fluid Markers of Alzheimer's Disease

van Gool, W. A., & Bolhuis, P. A. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb04052.x · Cited by 20 · see citing works

Biochemical profile of human infant cerebrospinal fluid in intraventricular hemorrhage and post-hemorrhagic hydrocephalus of prematurity

Otun, A., Morales, D. M., García‐Bonilla, M., Goldberg, S., Castañeyra-Ruiz, L., Yan, Y., Isaacs, A. M., Strahle, J. M., McAllister, J. P., & Limbrick, D. D. (2021) · Fluids and Barriers of the CNS · doi:10.1186/s12987-021-00295-8 · Cited by 18 · see citing works

Ion and Water Transport across the Blood–Brain Barrier

O’Donnell, M. E. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374373-2.00030-3 · Cited by 17 · see citing works

Vasopressin levels in CSF of Alzheimer patients: Correlations with monoamine metabolites and neuropsychological test performance

Jolkkonen, J., Helkala, E.-L., Kutvonen, R., Lehtinen, M., & Riekkinen, P. J. (1989) · Psychoneuroendocrinology · doi:10.1016/0306-4530(89)90057-7 · Cited by 16 · see citing works

Plasma copeptin and metabolic dysfunction in individuals with bipolar disorder

Mansur, R. B., Rizzo, L. B., Santos, C. M., Asevedo, E. D. M., da Cunha, G. R., Noto, M. N., Pedrini, M., Zeni‐Graiff, M., Cordeiro, Q., McIntyre, R. S., et al. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12535 · Cited by 15 · see citing works

Treatment of Vasogenic Brain Edema with Arginine Vasopressin Receptor Antagonist — an Experimental Study

Nagao, S., Kagawa, M., Bemana, I., Kuniyoshi, T., Ogawa, T., Honma, Y., & Kuyama, H. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9334-1_137 · Cited by 15 · see citing works

Association between bipolar episodes and fluid and electrolyte homeostasis: a retrospective longitudinal study

Hochman, E., Weizman, A., Valevski, A., Fischel, T., & Krivoy, A. (2014) · Bipolar Disorders · doi:10.1111/bdi.12248 · Cited by 14 · see citing works

Vasopressin V 1a Receptors Regulate Cerebral Aquaporin 1 after Traumatic Brain Injury

Rauen, K., Pop, V., Trabold, R., Badaut, J., & Plesnila, N. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2019.6653 · Cited by 14 · see citing works

Peripheral measures of arginine vasopressin, atrial natriuretic peptide and adrenocorticotropic hormone in premenstrual syndrome

Rosenstein, D. L., Kalogeras, K. T., Kalafut, M. A., Malley, J. D., & Rubinow, D. R. (1996) · Psychoneuroendocrinology · doi:10.1016/0306-4530(95)00035-6 · Cited by 14 · see citing works

Plasmatic vasopressin neurophysin in depression: Basic levels and relations with HPA axis

Laruelle, M. A., Seghers, A., Goffinet, S., Bouchez, S., & Legros, J. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90423-y · Cited by 14 · see citing works

Recent Developments in Gerontopsychiatric Research on Age-Associated Dementia in Japan

Homma, A., & Hasegawa, K. (1989) · International Psychogeriatrics · doi:10.1017/s1041610289000049 · Cited by 13 · see citing works

Vasopressin and vasopressin analogues for treatment of memory disorders in clinical practice

Lecros, J.-J., & Timsit-Berthier, M. (1988) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(88)90074-7 · Cited by 13 · see citing works

Vasopressin-neurophysin and bipolar depression

Legros, J., & Ansseau, M. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90226-x · Cited by 12 · see citing works

Syndrome of inappropriate secretion of antidiuretic hormone associated with schizophrenia

Suzuki, M., Takeuchi, O., Mori, I., Takegoshi, K., & Kurachi, M. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90098-k · Cited by 12 · see citing works

Antidiuretic hormone release associated with increased intracranial pressure independent of plasma osmolality

Keller, W. J., & Mullaj, E. (2018) · Brain and Behavior · doi:10.1002/brb3.1005 · Cited by 11 · see citing works

Intracerebroventricular arginine vasopressin causes intracranial pressure to rise in conscious goats

Seckl, J. R., & Lightman, S. L. (1987) · Brain Research · doi:10.1016/0006-8993(87)90850-x · Cited by 11 · see citing works

Electroencephalographic and early communicative abnormalities in Brattleboro rats

Lin, R. E., Ambler, L., Billingslea, E. N., Suh, J., Batheja, S., Tatard-Leitman, V. M., Featherstone, R. E., & Siegel, S. J. (2013) · Physiological Reports · doi:10.1002/phy2.100 · Cited by 11 · see citing works

Intracerebroventricular vasopressin reduces CSF absorption rate in the conscious goat

Seckl, J. R., & Lightman, S. L. (1991) · Experimental Brain Research · doi:10.1007/bf00231772 · Cited by 11 · see citing works

Attenuation of cryogenic induced brain oedema by arginine vasopressin release inhibitor RU51599

Ikeda, Y., Teramoto, A., Nakagawa, Y., Ishibashi, Y., & Yoshii, T. (1997) · Acta Neurochirurgica · doi:10.1007/bf01410979 · Cited by 11 · see citing works

Increased intracranial pressure is associated with elevated cerebrospinal fluid ADH levels in closed-head injury

Widmayer, M. A., Browning, J. L., Gopinath, S. P., Robertson, C. S., & Baskin, D. S. (2010) · Neurological Research · doi:10.1179/016164110x12714125204155 · Cited by 8 · see citing works

The Role of the Choroid Plexus in the Transport and Production of Polypeptides

Silverberg, G. D., Szmydynger‐Chodobska, J., & Chodobski, A. (2005) · CRC Press eBooks · doi:10.1201/9781420023404.ch10 · Cited by 8 · see citing works

Neuropeptides of the human magnocellular hypothalamus

Pałasz, A., Vecchia, A. D., Saganiak, K., & Worthington, J. J. (2021) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2021.102003 · Cited by 7 · see citing works

The clinical manifestation and treatment of Meniere's Disease from the viewpoint of the water homeostasis of the inner ear

Takeda, T., Takeda, S., & Kakigi, A. (2024) · Auris Nasus Larynx · doi:10.1016/j.anl.2024.08.002 · Cited by 7 · see citing works

Neuropeptidases

Hui, K. S. (2007) · Springer eBooks · doi:10.1007/978-0-387-30379-6_21 · Cited by 7 · see citing works

Increase in vasopressin binding sites in the human choroid plexus in Alzheimer's disease

Korting, C., van Zwieten, E. J., Boer, G. J., Ravid, R., & Swaab, D. F. (1996) · Brain Research · doi:10.1016/0006-8993(95)01242-7 · Cited by 7 · see citing works

Manic–depression neural conduction speeds and action potential event dyscorrelation

Newton, J. R. (1999) · Medical Hypotheses · doi:10.1054/mehy.1997.0610 · Cited by 7 · see citing works

Neuropeptides in Alzheimer's Disease: Clinical implications

Mazurek, M. F., Beal, M. F., & Martin, J. B. (1986) · Neurologic Clinics · doi:10.1016/s0733-8619(18)30946-0 · Cited by 7 · see citing works

Corticosterone oscillations during mania induction in the lateral hypothalamic kindled rat—Experimental observations and mathematical modeling

Abulseoud, O. A., Ho, A. M., Choi, D., Stanojević, A., Čupić, Ž., Kolar-Anic, L. Z., & Vukojević, V. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177551 · Cited by 5 · see citing works

Neurohormones in Depression and Anxiety

Altemus, M. M., & Gold, P. W. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-631330-7.50017-4 · Cited by 5 · see citing works

Dementias (Alzheimer's and Pick's Disease): Dysfunctional and Structural Changes

STIGSBY, B. (1988) · American Journal of EEG Technology · doi:10.1080/00029238.1988.11080251 · Cited by 3 · see citing works

Therapeutic potential of vasopressin in the treatment of neurological disorders

Mishra, S., Grewal, J., Wal, P., Bhivshet, G. U., Tripathi, A. K., & Walia, V. (2024) · Peptides · doi:10.1016/j.peptides.2024.171166 · Cited by 2 · see citing works

Experimental Therapies for Brain Edema and Intracranial Hypertension

Rauen, K., & Plesnila, N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803196-4.00019-9 · Cited by 2 · see citing works

Blood-Brain Barrier Mechanisms of Edema Formation

O’Donnell, M. E., Wulff, H., & Chen, Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803196-4.00007-2 · Cited by 2 · see citing works

Effect of Niravoline (RU51599), a κ-Opioid Receptor Agonist, on Tumour-Origin Brain Oedema

Takahashi, H., Hamada, H., & Teramoto, A. (1999) · Acta Neurochirurgica · doi:10.1007/s007010050374 · Cited by 1 · see citing works

Dementia and neuropeptides

Gottfries, C. G. (1991) · European Neuropsychopharmacology · doi:10.1016/0924-977x(91)90583-g · Cited by 1 · see citing works

Changes of the Neuroendocrine System in Alzheimer-type Dementia

Kiuchi, Y., Parvez, H. S., Parvez, S., & Yasuhara, H. (1992) · doi:10.1007/978-1-349-12275-2_7 · Cited by 1 · see citing works

Effect of Cerebroventricular Infusion of Vasopressin on Intracranial Pressure, Blood Pressure and Plasma Vasopressin

Sørensen, P. S., & Gyring, J. (1986) · Springer eBooks · doi:10.1007/978-3-642-70971-5_95 · Cited by 1 · see citing works

Impaired repression at a vasopressin promoter polymorphism in a rat model of trait anxiety and depression

Murgatroyd, C. (2005) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.3592

Biocapteurs implantables pour un monitorage intracérébral minimalement invasif

Chatard, C. (2018) · doi:10.70675/1880b7a0z30d6z4a12za2b9za72ac2b0053b

CSF and plasma vasopressin concentrations in dementia.

Sørensen, P. S., HAMMER, M., Vorstrup, S., & Gjerris, F. (1983) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.46.10.911 · Cited by 52 · see citing works

Cerebrospinal fluid vasopressin and increased intracranial pressure

Sørensen, P. S., Gjerris, F., & HAMMER, M. (1984) · Annals of Neurology · doi:10.1002/ana.410150506 · Cited by 52 · see citing works

Cerebrospinal Fluid Vasopressin—Changes in Depression

Gjerris, A., Vendsborg, P. B., HAMMER, M., Christensen, N. J., & Rafaelsen, O. J. (1985) · The British Journal of Psychiatry · doi:10.1192/bjp.147.6.696 · Cited by 69 · see citing works

Cerebrospinal fluid vasopressin in benign intracranial hypertension

Sørensen, P. S., HAMMER, M., & Gjerris, F. (1982) · Neurology · doi:10.1212/wnl.32.11.1255 · Cited by 34 · see citing works

Studies of vasopressin in the human cerebrospinal fluid

Sørensen, P. S. (1986) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1986.tb04633.x · Cited by 41 · see citing works